Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Revenue (2020 - 2025)

Historic Revenue for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $138.7 million.

  • Bioventus' Revenue fell 22.52% to $138.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $563.8 million, marking a year-over-year increase of 157.96%. This contributed to the annual value of $573.3 million for FY2024, which is 1189.34% up from last year.
  • According to the latest figures from Q3 2025, Bioventus' Revenue is $138.7 million, which was down 22.52% from $147.7 million recorded in Q2 2025.
  • Bioventus' 5-year Revenue high stood at $153.6 million for Q4 2024, and its period low was $81.8 million during Q2 2021.
  • Moreover, its 5-year median value for Revenue was $129.5 million (2024), whereas its average is $128.4 million.
  • As far as peak fluctuations go, Bioventus' Revenue skyrocketed by 8928.25% in 2021, and later plummeted by 611.52% in 2023.
  • Bioventus' Revenue (Quarter) stood at $130.4 million in 2021, then decreased by 3.51% to $125.8 million in 2022, then grew by 7.62% to $135.4 million in 2023, then rose by 13.45% to $153.6 million in 2024, then decreased by 9.76% to $138.7 million in 2025.
  • Its Revenue stands at $138.7 million for Q3 2025, versus $147.7 million for Q2 2025 and $123.9 million for Q1 2025.